A novel 4-1BB/HER2 bispecific antibody shows potent antitumor activities by increasing and activating tumor-infiltrating T cells.
Am J Cancer Res
; 13(7): 3246-3256, 2023.
Article
in En
| MEDLINE
| ID: mdl-37559991
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Language:
En
Journal:
Am J Cancer Res
Year:
2023
Document type:
Article
Affiliation country:
China